IV Disinfecting Caps Market Players:
- Human Metabolome Technologies America Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Thermo Fisher Scientific Inc.   Â
- Bio-Rad Laboratories, Inc.
- Biocrates life sciences AG
- Agilent Technologies, Inc.                      Â
- Merit Medical Systems
- B. Braun Melsungen AG
- ICU Medical, Inc.
- Becton, Dickinson and Company
- 3M Company
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of IV disinfecting caps is evaluated at USD 505.92 billion.
The global IV disinfecting caps market size was worth around USD 463 billion in 2025 and is set to register a CAGR of more than 10.3%, exceeding USD 1.23 trillion revenue by 2035.
North America is expected to command a 35% share by 2035 in the IV disinfecting caps market, stemming from the escalating volume of surgical procedures.
Key players in the market include Human Metabolome Technologies America Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Biocrates life sciences AG, Agilent Technologies, Inc., Merit Medical Systems, B. Braun Melsungen AG, ICU Medical, Inc., Becton, Dickinson and Company, 3M Company.
